Spain · Delayed Price · Currency is EUR Naturhouse Health Statistics
Total Valuation
BME:NTH has a market cap or net worth of EUR 152.27 million. The enterprise value is 147.63 million.
| Market Cap | 152.27M |
| Enterprise Value | 147.63M |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Apr 16, 2026 |
Share Statistics
BME:NTH has 59.95 million shares outstanding. The number of shares has decreased by -3.68% in one year.
| Current Share Class | 59.95M |
| Shares Outstanding | 59.95M |
| Shares Change (YoY) | -3.68% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.74% |
| Float | 13.00M |
Valuation Ratios
The trailing PE ratio is 14.94.
| PE Ratio | 14.94 |
| Forward PE | n/a |
| PS Ratio | 3.20 |
| PB Ratio | 8.57 |
| P/TBV Ratio | 8.76 |
| P/FCF Ratio | 13.04 |
| P/OCF Ratio | 12.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.14, with an EV/FCF ratio of 12.65.
| EV / Earnings | 14.63 |
| EV / Sales | 3.10 |
| EV / EBITDA | 10.14 |
| EV / EBIT | 10.99 |
| EV / FCF | 12.65 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.65 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 0.62 |
| Debt / FCF | 0.77 |
| Interest Coverage | 150.49 |
Financial Efficiency
Return on equity (ROE) is 40.83% and return on invested capital (ROIC) is 74.47%.
| Return on Equity (ROE) | 40.83% |
| Return on Assets (ROA) | 21.77% |
| Return on Invested Capital (ROIC) | 74.47% |
| Return on Capital Employed (ROCE) | 61.44% |
| Weighted Average Cost of Capital (WACC) | 5.85% |
| Revenue Per Employee | 258,853 |
| Profits Per Employee | 54,859 |
| Employee Count | 184 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 4.20 |
Taxes
In the past 12 months, BME:NTH has paid 3.60 million in taxes.
| Income Tax | 3.60M |
| Effective Tax Rate | 26.29% |
Stock Price Statistics
The stock price has increased by +47.67% in the last 52 weeks. The beta is 0.35, so BME:NTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +47.67% |
| 50-Day Moving Average | 2.55 |
| 200-Day Moving Average | 2.18 |
| Relative Strength Index (RSI) | 50.51 |
| Average Volume (20 Days) | 38,527 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:NTH had revenue of EUR 47.63 million and earned 10.09 million in profits. Earnings per share was 0.17.
| Revenue | 47.63M |
| Gross Profit | 34.27M |
| Operating Income | 13.24M |
| Pretax Income | 13.70M |
| Net Income | 10.09M |
| EBITDA | 14.38M |
| EBIT | 13.24M |
| Earnings Per Share (EPS) | 0.17 |
Balance Sheet
The company has 13.59 million in cash and 8.93 million in debt, with a net cash position of 4.65 million or 0.08 per share.
| Cash & Cash Equivalents | 13.59M |
| Total Debt | 8.93M |
| Net Cash | 4.65M |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 17.76M |
| Book Value Per Share | 0.30 |
| Working Capital | 7.71M |
Cash Flow
In the last 12 months, operating cash flow was 12.15 million and capital expenditures -472,000, giving a free cash flow of 11.67 million.
| Operating Cash Flow | 12.15M |
| Capital Expenditures | -472,000 |
| Depreciation & Amortization | 1.14M |
| Net Borrowing | -953,000 |
| Free Cash Flow | 11.67M |
| FCF Per Share | 0.19 |
Margins
Gross margin is 71.95%, with operating and profit margins of 27.80% and 21.19%.
| Gross Margin | 71.95% |
| Operating Margin | 27.80% |
| Pretax Margin | 28.75% |
| Profit Margin | 21.19% |
| EBITDA Margin | 30.19% |
| EBIT Margin | 27.80% |
| FCF Margin | 24.51% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 7.97%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 7.97% |
| Dividend Growth (YoY) | 75.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 178.32% |
| Buyback Yield | 3.68% |
| Shareholder Yield | 11.65% |
| Earnings Yield | 6.63% |
| FCF Yield | 7.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |